Embla Medical hf. (OSSFF)

4.53

0.00 (0.00%)

Stock details

Previous close: 4.525$
Day's range: 4.53 - 4.53$
52-week range: 4.15 - 5.33$
Volume: 200
Average volume: 891
Beta: 1.06
EPS (TTM): 0.22
PE ratio (TTM): 21.04
Forward P/E: 19.08
Market cap: 1 933 114 992
Shares outstanding: 427 207 733
Dividend yield: N/A
Next earnings date: 2026-10-20
Sector: Healthcare
Industry: Medical Devices

About the company

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microp... read more

CEO: Sveinn Solvason
Country: Iceland
IPO Date: 2009-01-01
Employees: 4500
Fiscal Year End: January - December
Website: https://www.emblamedical.com

Revenue Breakdown

No Data

Revenue breakdown data has not been calculated yet.

News

No Data

There are no news for this stock.

Chart: OSSFF

Loading Chart...

Overall Score

1 / 1010%

Octagon View

Strength & Weakness

Cash reserves $0.0 barely cover the upcoming debt maturities $0.0

Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity

Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage

Financial Strength

NAME	RATIO	INDUSTRY	SCORE
Current ratio	N/A	2.26	N/A
Quick ratio	N/A	1.64	N/A
Debt to Equity	N/A	0.59	N/A
Debt to Assets	N/A	0.28	N/A
Interest coverage	N/A	6.80	N/A
Weighted average score			N/A

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)

Values in USD (B=Billions, M=Millions, K=Thousands)

METRIC	TTM
Total Revenue	N/A
Gross Profit	N/A
Operating Income	N/A
Net Income	N/A
EBITDA	N/A

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAME	RATIO	INDUSTRY	SCORE
Gross margin %	N/A	55.95	N/A
Operating margin %	N/A	15.33	N/A
Net margin %	N/A	8.89	N/A
EBITDA margin %	N/A	20.34	N/A
Cash flow margin %	N/A	-13.63	N/A
Weighted average score			N/A

Net Margin

Effectiveness

NAME	RATIO	INDUSTRY	SCORE
ROA	N/A	4.47	N/A
ROE	N/A	8.78	N/A
ROIC	N/A	5.69	N/A
ROCE	N/A	17.85	N/A
Weighted average score			N/A

Estimated EPS vs Actual EPS

Forecast

NAME	REVENUE GROWTH	EPS GROWTH	SCORE
Current quarter	N/A	N/A	N/A
Next quarter	N/A	N/A	N/A
Current year	N/A	N/A	N/A
Next year	N/A	N/A	N/A
Weighted average score			N/A

Analyst Rating

Growth

NAME	REVENUE	NET INCOME	EPS	FCF	SCORE
Q/Q	N/A	N/A	N/A	N/A	N/A
Y/Y	N/A	N/A	N/A	N/A	N/A
3y average	N/A	N/A	N/A	N/A	N/A
5y average	N/A	N/A	N/A	N/A	N/A
Weighted average score					N/A

Revenue Growth Rate vs. Industry

Valuation

NAME	RATIO	INDUSTRY	SCORE
P/E	N/A	31.12	N/A
PEG (5yr expected)	N/A	2.90	N/A
P/S	N/A	3.43	N/A
P/B	N/A	3.37	N/A
Weighted average score			N/A

DCF Model

Data not available

DCF model data has not been calculated yet.

Dividend

NAME	CURRENT	INDUSTRY	SCORE
Dividend yield	0.00	N/A	1.0
Payout ratio	0.00	N/A	1.0
5-year dividend growth rate	N/A	N/A	1.0
Years of dividend increase	N/A	N/A	1.0
Weighted average score			1.0

Fair Value

Data not available

Fair Value data has not been calculated yet.

Economic Moat

NAME	SCALE	SCORE
Market share	None	1.0
Intangible assets	None	1.0
Switching costs	None	1.0
Network effect	None	1.0
Economies of scale	None	1.0
Weighted average score		1.0

About the company

CEO

Sveinn Solvason

Country

Iceland

IPO Date

2009-01-01

Employees

4500

Fiscal Year End

January - December

Website

https://www.emblamedical.com

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Current ratio

N/A

2.26

N/A

Quick ratio

N/A

1.64

N/A

Debt to Equity

N/A

0.59

N/A

Debt to Assets

N/A

0.28

N/A

Interest coverage

N/A

6.80

N/A

Weighted average score

N/A

METRIC

TTM

Total Revenue

N/A

Gross Profit

N/A

Operating Income

N/A

Net Income

N/A

EBITDA

N/A

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Gross margin %

N/A

55.95

N/A

Operating margin %

N/A

15.33

N/A

Net margin %

N/A

8.89

N/A

EBITDA margin %

N/A

20.34

N/A

Cash flow margin %

N/A

-13.63

N/A

Weighted average score

N/A

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

ROA

N/A

4.47

N/A

ROE

N/A

8.78

N/A

ROIC

N/A

5.69

N/A

ROCE

N/A

17.85

N/A

Weighted average score

N/A

NAME

REVENUE GROWTH

EPS GROWTH

SCORE

Current quarter

N/A

Next quarter

N/A

Current year

N/A

Next year

N/A

Weighted average score

N/A

NAME

REVENUE

NET INCOME

EPS

FCF

SCORE

Q/Q

N/A

Y/Y

N/A

3y average

N/A

5y average

N/A

Weighted average score

N/A

NAME

RATIO

INDUSTRY

5Q TREND

SCORE

P/E

N/A

31.12

N/A

PEG (5yr expected)

N/A

2.90

N/A

P/S

N/A

3.43

N/A

P/B

N/A

3.37

N/A

Weighted average score

N/A

NAME

CURRENT

INDUSTRY

SCORE

Dividend yield

0.00

N/A

1.0

Payout ratio

0.00

N/A

1.0

5-year dividend growth rate

N/A

1.0

Years of dividend increase

N/A

1.0

Weighted average score

1.0

NAME

SCALE

SCORE

Market share

None

1.0

Intangible assets

None

1.0

Switching costs

None

1.0

Network effect

None

1.0

Economies of scale

None

1.0

Weighted average score

1.0

Search stocks

Embla Medical hf. (OSSFF)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Embla Medical hf. (OSSFF)

Stock details

About the company

Revenue Breakdown

No Data

News

Chart: OSSFF

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Data not available

Dividend

Fair Value

Data not available

Economic Moat

Stock details

About the company

Revenue Breakdown

No Data

News

Chart: OSSFF

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Data not available

Dividend

Fair Value

Data not available

Economic Moat